Compare AMKR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMKR | RGEN |
|---|---|---|
| Founded | 1968 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 10.0B |
| IPO Year | 1997 | 1995 |
| Metric | AMKR | RGEN |
|---|---|---|
| Price | $53.03 | $179.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 22 |
| Target Price | $76.40 | ★ $189.70 |
| AVG Volume (30 Days) | ★ 3.2M | 880.1K |
| Earning Date | 10-26-2026 | 10-27-2026 |
| Dividend Yield | ★ 0.64% | N/A |
| EPS Growth | 4.90 | ★ 286.96 |
| EPS | ★ 0.33 | 0.24 |
| Revenue | ★ $4,052,650,000.00 | $141,236,000.00 |
| Revenue This Year | $14.27 | $12.04 |
| Revenue Next Year | $12.72 | $17.80 |
| P/E Ratio | ★ $165.39 | $805.46 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $28.32 | $100.99 |
| 52 Week High | $96.68 | $198.87 |
| Indicator | AMKR | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 50.72 | 63.35 |
| Support Level | $45.69 | $159.22 |
| Resistance Level | $52.22 | N/A |
| Average True Range (ATR) | 2.01 | 6.58 |
| MACD | 0.57 | 0.98 |
| Stochastic Oscillator | 69.54 | 75.63 |
Amkor Technology Inc is a OSAT (outsourced semiconductor assembly and test) service provider. It has pioneered the outsourcing of integrated circuit (IC) packaging and test services and is a strategic manufacturing partner for the semiconductor companies, foundries, and electronics original equipment manufacturers (OEMs). The firm's products are organized into two categories namely advanced products that include flip chip, fine pitch bumping, wafer-level processing, advanced SiPs, power modules, and others, and Mainstream products that includes wirebond packaging and testing. The company derives maximum revenue from the advanced products category. The company derives majority of its revenue from Foreign states.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.